ARTICLE | DERMAL REJUVENATION |
CO2 THERAPY
IRREGULARITIES
ADIPOSITIES AND SKIN
TO TREAT
Matteo Campana discusses the transcutaneous and subcutaneous administration of carbon dioxide for the treatment of adipose masses, such as cellulite and stretch marks
therapeutic purposes is known as CO2 therapy or
ABSTRACT The transcutaneous or subcutaneous administration of carbon dioxide (CO2
arteriolar vasodilatation, neoangiogenesis, artificial Bohr effect, and lipolytic effects. The use of CO2
carboxytherapy. The effects of transcutaneous and subcutaneous administration of CO2
are active is
related to its positive and documented effects on different aspects of the imperfection’s aetiology.
C 70 ❚ ARBON DIOXIDE (CO2 ) for
either in combination with surgical treatment, or alone, if patients refuse surgical treatment.
The adipose tissue is a connective tissue composed of fat cells, stromal elements, vessels (e.g. blood and lymph vessels), and a matrix of collagen fibres. Localised adiposity refers to the accumulation of fat in certain areas of the body. The goal of the therapy is to obtain a reduction in the volume of adipose masses, and therefore the use of CO2
is indicated
MATTEO CAMPANA, MD, Department of General and Specialist Surgery, Plastic Surgery Unit, University of Siena, Siena, Italy.
email:
matteocamp@gmail.com or subcutaneaous administration of CO2
) THERAPY REFERS TO THE TRANSCUTANEOUS for therapeutic purposes. This
treatment was developed in 1932 in the thermal station of Royat Spas of Clermont-Ferrand, France, which specialised in carbon gas balneotherapy in the treatment of patients affected by obliterating arteriopathies 1,2 Italian contribution has been remarkable in this field of research; in
.
1964, Re et al published a monograph entitled ÔLa cura termale delle malattie cuore e dei vasiÕ (Thermal therapy in the treatment of cardiovascular disease), which illustrated the importance of CO2
applications in these pathologies 3 .
In 1995, Parassoni, speaking at the XVI National Congress of Aesthetic Medicine in Rome, introduced the term ÔcarbossiterapiaÕ 4
developed the first device for the administration of CO2 March 2013 |
prime-journal.com
(carboxytherapy). Re and Parassoni also .
KEYWORDS local adiposities, carboxytherapy, cellulite, peripheral arteriopathies, vascular acrosyndromes, lipomatosis, liposuction
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88 |
Page 89 |
Page 90 |
Page 91 |
Page 92 |
Page 93 |
Page 94 |
Page 95 |
Page 96 |
Page 97 |
Page 98 |
Page 99 |
Page 100 |
Page 101 |
Page 102 |
Page 103 |
Page 104 |
Page 105 |
Page 106 |
Page 107 |
Page 108 |
Page 109 |
Page 110 |
Page 111 |
Page 112 |
Page 113 |
Page 114 |
Page 115 |
Page 116 |
Page 117 |
Page 118 |
Page 119 |
Page 120 |
Page 121 |
Page 122 |
Page 123 |
Page 124 |
Page 125 |
Page 126 |
Page 127 |
Page 128 |
Page 129 |
Page 130 |
Page 131 |
Page 132 |
Page 133 |
Page 134 |
Page 135 |
Page 136 |
Page 137 |
Page 138 |
Page 139 |
Page 140